Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.36 |
| ▸ | BLM | P54132 | 3/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.36 |
| ▸ | GMNN | O75496 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | APEX1 | P27695 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 4/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | TERT | O14746 | 3/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | FABP4 | P15090 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8852659 | 0.93 | LPAR2 (0.30) | F7F3 | |
| SCHEMBL8852654 | 0.93 | LPAR2 (0.30) | F7F3 | |
| SCHEMBL17748990 | 0.86 | — | — | |
| SCHEMBL1027367 | 0.82 | — | — | |
| SCHEMBL17652427 | 0.79 | FAAH (0.38) | CYP1A2CYP2C19BLMHSD17B10GMNN | |
| Boric Acid SCHEMBL28274028 | 0.75 | CYP1A2 (0.40) | CYP1A2CYP2C19BLMHSD17B10GMNN | |
| SCHEMBL5951981 | 0.72 | — | — | |
| SCHEMBL6437849 | 0.72 | LPAR3 (0.40) | CNR1CNR2F7F3 | |
| SCHEMBL17505971 | 0.71 | KDM4E (0.31) | — | |
| SCHEMBL6436772 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9711737-B2 | Photoelectric conversion element and solid-state imaging device | SONY CORPORATION (JP) | 2017-07-18 | — | — | US | disclosed |
| US-20160049595-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND SOLID-STATE IMAGING DEVICE | SONY CORPORATION (JP) | 2016-02-18 | — | — | US | disclosed |
| US-9123901-B2 | Photoelectric conversion element and solid-state imaging device | SONY CORPORATION (JP) | 2015-09-01 | — | — | US | disclosed |
| US-8546796-B2 | Semiconductor device, method of manufacturing the same, and method of forming multilayer semiconductor thin film | SONY CORPORATION (JP) | 2013-10-01 | — | — | US | disclosed |
| US-20130200343-A1 | SEMICONDUCTOR DEVICE, METHOD OF MANUFACTURING THE SAME, AND METHOD OF FORMING MULTILAYER SEMICONDUCTOR THIN FILM | SONY CORPORATION (JP) | 2013-08-08 | — | — | US | disclosed |
| EP-2592670-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND SOLID STATE IMAGING DEVICE | Sony Corporation (JP) | 2013-05-15 | — | — | EP | disclosed |
| US-20130099225-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND SOLID-STATE IMAGING DEVICE | SONY CORPORATION (JP) | 2013-04-25 | — | — | US | disclosed |
| US-8399288-B2 | Semiconductor device, method of manufacturing the same, and method of forming multilayer semiconductor thin film | SONY CORPORATION (JP) | 2013-03-19 | — | — | US | disclosed |
| US-20120025173-A1 | SEMICONDUCTOR DEVICE, METHOD OF MANUFACTURING THE SAME, AND METHOD OF FORMING MULTILAYER SEMICONDUCTOR THIN FILM | SONY CORPORATION (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20090289248-A1 | DIOXAANTHANTHRENE COMPOUND AND SEMICONDUCTOR DEVICE | SONY CORPORATION (JP) | 2009-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090289248-A1 | DIOXAANTHANTHRENE COMPOUND AND SEMICONDUCTOR DEVICE | DDT, DHX9, DHX29 | CYP1A2 81/4885CYP2C19 75/4885BLM 223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.